Clinical Trial Update: Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a slowed carboplatin infusion during re-treatment for ovarian cancer was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Recurrent Ovarian Cancer, Platinum Sensitive Ovarian Cancer | Phase 4 | Status: TERMINATED | Results posted: 2016-11-01